News
Tower Cold Chain wins Queen’s Award for International Trade
Pharmaceutical temperature-controlled specialist Tower Cold Chain has been honoured with a Queen’s Award for Enterprise, the UK’s highest accolade for business success. The company won its award for International Trade for Outstanding Short Term Growth in export sales made...
News
Ontario and Quebec become the first provinces to list Kesimpta for the treatment of adults with relapsing remitting multiple sclerosis
Novartis Pharmaceuticals Canada Inc. is pleased to announce that PrKesimpta® (ofatumumab) is now covered under the Ontario Exceptional Access Program (EAP) and included on the Régie de l’assurance maladie du Québec (RAMQ) List of Medications as an Exceptional Medication for...
News
FDA Wants To Know How Patients, Doctors Decide Prescriptions
The FDA's Office of Prescription Medicine Promotion (OPDP) intends to know how patients and doctors consider the risks and benefits of a new prescription medicine before starting it. What factors influence treatment decisions, and how do people choose one medication...
News
200M COVID Jab Left Over Doses Leads SII Halting Production
As worldwide demand dwindles, around 200 million doses of COVID-19 vaccine are rusting away in the world's largest vaccine manufacturer's warehouses.
As per Bloomberg, Serum Institute of India (SII) CEO Adar Poonawalla revealed at the India Economic Conclave that they had ceased...
News
Sanofi Starts Work On €400 Million Smart Space In Singapore
Sanofi's "factory of the future" in Singapore could be operational by the middle of the decade. One of two so-called Evolutive Vaccine Facilities (EVFs) that the French drugmaker is building with a collective investment of 900 million euros (about...
News
NorthEdge invests in leading Life Sciences marketing specialist
Lower mid-market private equity firm NorthEdge has completed its investment into life sciences marketing agency, ramarketing, to support rapid service expansion and increased international presence.
North-East headquartered ramarketing employs more than 50 people globally with offices in Newcastle, Manchester and...
News
Samsung Biologics completes full acquisition of Samsung Bioepis
Samsung Biologics announced that it has completed the purchase of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion. With the completion of the first payment of USD $1.0 billion pursuant to the terms of the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read